"Chemokine CCL19" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards T LYMPHOCYTES and B LYMPHOCYTES.
| Descriptor ID |
D054415
|
| MeSH Number(s) |
D12.644.276.374.200.110.870 D12.644.276.374.200.600.870 D12.776.467.374.200.110.870 D12.776.467.374.200.600.870 D23.125.300.110.870 D23.125.300.600.870 D23.469.200.110.870 D23.469.200.600.870 D23.529.374.200.110.870 D23.529.374.200.600.870
|
| Concept/Terms |
Chemokine CCL19- Chemokine CCL19
- CCL19, Chemokine
- EBI1-Ligand Chemokine
- Chemokine, EBI1-Ligand
- EBI1 Ligand Chemokine
- ELC Chemokine
- Chemokine, ELC
- Exodus-3 Chemokine
- Chemokine, Exodus-3
- Exodus 3 Chemokine
- Macrophage Inflammatory Protein 3-beta
- Macrophage Inflammatory Protein 3 beta
- MIP-3beta
- MIP 3beta
- CCL19 Chemokine
- Chemokine, CCL19
- Epstein-Barr Virus-Induced Molecule 1 Ligand Chemokine
- Epstein Barr Virus Induced Molecule 1 Ligand Chemokine
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL19".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL19".
This graph shows the total number of publications written about "Chemokine CCL19" by people in this website by year, and whether "Chemokine CCL19" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL19" by people in Profiles.
-
Lymphoidal chemokine CCL19 promoted the heterogeneity of the breast tumor cell motility within a 3D microenvironment revealed by a Lévy distribution analysis. Integr Biol (Camb). 2020 02 22; 12(1):12-20.
-
A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients. Sci Rep. 2016 11 07; 6:36440.
-
Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol (Camb). 2012 Apr; 4(4):401-9.
-
Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor ß1. Cytokine. 2011 Sep; 55(3):372-9.
-
Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc Natl Acad Sci U S A. 2011 Apr 05; 108(14):5614-9.
-
Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J Exp Med. 2010 Mar 15; 207(3):591-605.
-
In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol. 2009 Dec 15; 183(12):8004-14.
-
An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomed Microdevices. 2009 Aug; 11(4):827-35.
-
Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration. J Immunol. 2008 Oct 15; 181(8):5560-7.
-
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. J Leukoc Biol. 2003 Jul; 74(1):69-80.